PDR MEMBER LOGIN:
  • PDR Search

    Required field
  • IMPORTANT DRUG WARNING

    Product: Xeljanz® (tofacitinib)
    Posted On: March 19, 2021
    MANUFACTURER: Pfizer
    AUDIENCE: Prescribers: Healthcare Professionals not included in the October 2020 communication - AMA Rheumatology, Pediatrics, Pediatric Rheumatology, Rheumatology Nurse Practitioners and Physician Assistants, Pharmacists and Pharmacies.

    If unable to view, click here to download this file to your computer.